Brainstorm Cell Therapeutics reported $14.49M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US 15.9M 9.98M
Biogen BIIB:US $ 11242.3M 346.1M
Brainstorm Cell Therapeutics BCLI:US $ 14.49M 4.86M
Cerulean Pharma CERU:US $ 30.88M 7.88M
Cytokinetics CYTK:US $ 116.26M 127.6M
Gilead Sciences GILD:US $ 19927M 1142M
Halozyme Therapeutics HALO:US $ 260.26M 63.3M
Idera Pharmaceuticals IDRA:US $ 25.84M 3.61M